Thompson Davis & Co’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Thompson Davis & Co’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-179	Closed	-$3K	–	1233
2016 Q1	$3K	Hold	179	–	–	﹤0.01%	918
2015 Q4	$4K	Buy	+179	New	+$3.48K	0.01%	909
2015 Q3	–	Sell	-250	Closed	-$9K	–	1318
2015 Q2	$9K	Buy	+250	New	+$7.63K	0.01%	755
2015 Q1	–	Sell	-6,500	Closed	-$84K	–	1322
2014 Q4	$84K	Buy	+6,500	New	+$81.4K	0.1%	205
2014 Q3	–	Sell	-26,250	Closed	-$415K	–	1296
2014 Q2	$415K	Buy	26,250 +21,250	+425%	+$303K	0.6%	36
2014 Q1	$76K	Buy	+5,000	New	+$56.5K	0.13%	194

Other funds holding HZNP

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return